Bio-Techne has outperformed the Nasdaq over the past year, but analysts are cautious about the stock’s prospects.
Is Bio-Techne Stock Outperforming the Nasdaq?
view original post
Bio-Techne has outperformed the Nasdaq over the past year, but analysts are cautious about the stock’s prospects.